Author： Bouhassira E.E. Acharya A.S.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.7, 2000-07, pp. : 1081-1093
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease
Current Gene Therapy, Vol. 10, Iss. 5, 2010-10 ,pp. :
Access to resources
Recommend
Drug therapy for sickle cell disease
By Iyamu Efemwonkiekie W Asakura Toshio
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. :
Expression of a human antisickling -globin gene variant corrected sickle cell disease
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :
By Yardumian Anne Crawley Charles
Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. :
Sickle Cell Disease in Children
Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. :